[at noodls] – LIVINGSTON, NJ – October 25, 2012 -Columbia Laboratories Inc. (Nasdaq:CBRX) today confirmed that the U.S. Food and Drug Administration (FDA) has denied Watson Pharmaceuticals’ (NYSE:WPI) Formal Dispute … moreView todays social media effects on CBRXView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – LIVINGSTON, NJ – October 25, 2012 – Columbia Laboratories Inc. (Nasdaq: CBRX) will hold a conference call on November 8, 2012, to discuss financial results of the three-month period ended September 30, … moreView todays social media effects on CBRXView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – LIVINGSTON, NJ – October 25, 2012 – Columbia Laboratories Inc. (Nasdaq: CBRX) (the Company) received a letter on October 24, 2012, from the NasdaqStock Market indicating that the Company no … moreView todays social media effects on CBRXView the latest stocks trending across Twitter. Click to view dashboard […]
